Airborne disease detection made easier with new, low-cost device
Airborne hazardous chemicals can be dilute, mobile and hard to trap. Yet, accurately measuring these chemicals is critical in protecting human health and the environment.
Now, a new, small, low-cost device, nicknamed ABLE, could make the collection and detection of airborne hazards much more efficient. The device, just four by eight inches across, was devised by Jingcheng Ma, assistant professor of aerospace and mechanical engineering at the University of Notre Dame, and researchers at the University of Chicago. The results of their work were published in Nature Chemical Engineering.
ABLE has immediate applications in hospitals, where viruses, bacteria and nanoplastics can be detected directly from the air — offering less invasive alternatives to blood draws, particularly for vulnerable infants in neonatal units.
“Many important biomarkers — molecules your body produces when it’s dealing with pathogens — are very dilute in the air. They could be at the parts per billion level. Trying to find them is like locating six to seven people in the global population — very difficult,” said Ma, the study’s first author, who conducted the research as a postdoc at the University of Chicago.
Ma, whose graduate training was in thermal science and energy systems — a field in which the transfer of water from liquid to steam is central — wondered how airborne biomarkers might behave if condensed into liquid. Could these molecules be captured in water droplets? Would their concentration in liquid be the same as their concentration in air? Would different molecules condense differently?
If airborne biomarkers are tested in gas form, large, expensive machines — such as mass spectrometers — are usually necessary. However, if the researchers could convert the air into a liquid, an array of low-cost, accurate measuring tools became available — paper-based test strips, electro-chemical sensors, enzyme assays and optical sensors.
“We discovered that many molecules can effectively enter water droplets even when their concentration is very low,” Ma said. “We didn’t need to develop any advanced chemical systems to capture these biomarkers in water. It’s a very natural process.”
The ABLE device, which can be made for under $200, sucks in air, adds water vapor and cools it. The air sample condenses into water droplets on a surface of microscopic silicon spikes — a process through which even tiny amounts of contaminant become highly concentrated. These droplets then slide into a reservoir where they are tested for biomarkers.
Ma’s research group, the Interfacial Thermofluids Lab (ITL), is exploring ways to miniaturize ABLE, enabling it to fit into portable sensing systems or robotic platforms for environmental and healthcare monitoring. The group is also working with community partners to monitor the health of vulnerable infants in neonatal care.
“I like to do what I call ‘budget research,’ that is, use simple and low-cost components, but do something important that no one has achieved before. I like research that delivers something everyone can buy from the store,” Ma said.
Ma’s work is supported by US Army Research Office, University of Chicago and University of Notre Dame startup grants, the Technology Development Fund from the Berthiaume Institute for Precision Health , the Grier Prize for Innovation Research in the Biophysical Sciences, and the National Institute of Health.
Contact: Brandi Wampler, associate director of media relations, 574-631-2632, brandiwampler@nd.edu
Latest ND NewsWire
- Notre Dame student uses ‘American Ninja Warrior’ spotlight to fight world hunger via his nonprofitOn July 14 (Monday), a University of Notre Dame business student will compete in the semifinal round of NBC’s “American Ninja Warrior” to advocate for an end to world hunger, an ambition he works toward by making knotted dog toys and collecting donations to his nonprofit.
- In sub-Saharan Africa, 1 in 6 cancer medications found to be defectiveSerious quality defects were found in a significant number of cancer medications from sub-Saharan Africa, according to new research from the University of Notre Dame.
- Alumni Association awards 2025 Lennon Life PrizesThe Notre Dame Alumni Association recognized nine alumni clubs as recipients of the Lennon Life Prize — part of the Chuck and Joan Lennon Gospel of Life Initiative, a set of programs focused on encouraging the University’s dedicated network of clubs to uphold the value of life at all stages.
- Prioritizing prenatal care may decrease low birth weight outcomes in The Gambia, Notre Dame research findsA new study co-authored by University of Notre Dame researchers highlights the importance of prenatal care for improving the health of mothers and newborns, providing evidence that can inform policy.
- Navigating the waters of peace: Researchers address challenges, opportunities in implementation of Colombia's Peace AgreementNearly half of the commitments outlined in Colombia's historic peace accord face significant challenges and may not happen in time unless policymakers make several key interventions, warns a new report from Notre Dame's Peace Accords Matrix. The report offers a blueprint to salvage an accord that has lagged behind its implementation deadlines, putting its legacy at risk. It highlights timely fixes that can strengthen the agreement.
- ‘Returnless returns’ boost brands among consumersReturnless returns can increase brand support by fostering goodwill, according to John Costello and Christopher Bechler, assistant professors of marketing at Notre Dame’s Mendoza College of Business. Their study, “Just Keep It: When and Why Returnless Product Returns Foster Brand Support,” is forthcoming in the Journal of Marketing Research.
